BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 2869709)

  • 1. New horizons in the pharmacologic management of peptic ulceration.
    Debas HT; Mulholland MW
    Am J Surg; 1986 Mar; 151(3):422-30. PubMed ID: 2869709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 3. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P; Ghiorzi A; Cereda E; Donetti A
    Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine H2-receptor antagonists and gastric acid secretion.
    Pounder RE
    Pharmacol Ther; 1984; 26(2):221-34. PubMed ID: 6152495
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 8. [The etiopathogenesis and therapy of gastric and duodenal ulcer].
    Lattanzi A
    Clin Ter; 1978 Sep; 86(6):515-35. PubMed ID: 367685
    [No Abstract]   [Full Text] [Related]  

  • 9. H2-receptor antagonists: development and application.
    Feldman S
    N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Which drug for peptic ulcer?].
    Hameeteman W; Tytgat GN
    Ned Tijdschr Geneeskd; 1985 Aug; 129(35):1673-6. PubMed ID: 2864643
    [No Abstract]   [Full Text] [Related]  

  • 11. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
    Contraşiu P; Calinici V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptic ulcer disease: physiology and pathophysiology.
    Holt KM; Isenberg JI
    Hosp Pract (Off Ed); 1985 Jan; 20(1):89-93, 96-101, 104-6. PubMed ID: 2856923
    [No Abstract]   [Full Text] [Related]  

  • 14. Cimetidine and ulcers.
    Br Med J; 1976 Nov; 2(6047):1275-6. PubMed ID: 11866
    [No Abstract]   [Full Text] [Related]  

  • 15. New histamine H2-receptor antagonists.
    Domschke S; Domschke W
    Hepatogastroenterology; 1980 Jun; 27(3):163-8. PubMed ID: 6109690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antisecretory and mucosa-protecting drugs in the acute care of peptic ulcer. Review of action principles, healing rates and side effects of approved ulcer drugs and drugs under clinical trial].
    Simon B; Müller P; Dammann HG
    Fortschr Med; 1984 Jul; 102(25-26):683-7. PubMed ID: 6147304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N; Miwa T
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Currents aspects of H2 receptor antagonists in the treatment of ulcers].
    Debongnie JC
    Acta Gastroenterol Belg; 1992; 55(5-6):415-22. PubMed ID: 1363166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptic ulceration in kidney transplantation.
    Ahonen J; Eklund B; Lindfors O; Kuhlbäck B; Lindström BL
    Proc Eur Dial Transplant Assoc; 1977; 14():396-400. PubMed ID: 23527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.